Report Detail

Request for Sample of this report

Pharma & Healthcare Global Oncology Targeted Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4652828
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncology Targeted Therapy market size was valued at US$ 63450 million in 2024 and is forecast to a readjusted size of USD 115840 million by 2031 with a CAGR of 9.1% during review period.
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Oncology Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology Targeted Therapy market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Targeted Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology Targeted Therapy market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Targeted Therapy, with revenue, gross margin, and global market share of Oncology Targeted Therapy from 2020 to 2025.
Chapter 3, the Oncology Targeted Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncology Targeted Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Targeted Therapy.
Chapter 13, to describe Oncology Targeted Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oncology Targeted Therapy by Type
    • 1.3.1 Overview: Global Oncology Targeted Therapy Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Oncology Targeted Therapy Consumption Value Market Share by Type in 2024
    • 1.3.3 Sorafenib
    • 1.3.4 Lenvatinib
    • 1.3.5 Regorafenib
    • 1.3.6 Osimertinib
    • 1.3.7 Anlotinib
    • 1.3.8 Alectinib
    • 1.3.9 Other
  • 1.4 Global Oncology Targeted Therapy Market by Application
    • 1.4.1 Overview: Global Oncology Targeted Therapy Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Oncology Targeted Therapy Market Size & Forecast
  • 1.6 Global Oncology Targeted Therapy Market Size and Forecast by Region
    • 1.6.1 Global Oncology Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Oncology Targeted Therapy Market Size by Region, (2020-2031)
    • 1.6.3 North America Oncology Targeted Therapy Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Oncology Targeted Therapy Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Oncology Targeted Therapy Market Size and Prospect (2020-2031)
    • 1.6.6 South America Oncology Targeted Therapy Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Oncology Targeted Therapy Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Oncology Targeted Therapy Product and Solutions
    • 2.1.4 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bayer Recent Developments and Future Plans
  • 2.2 Eisai
    • 2.2.1 Eisai Details
    • 2.2.2 Eisai Major Business
    • 2.2.3 Eisai Oncology Targeted Therapy Product and Solutions
    • 2.2.4 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Eisai Recent Developments and Future Plans
  • 2.3 Zelgen
    • 2.3.1 Zelgen Details
    • 2.3.2 Zelgen Major Business
    • 2.3.3 Zelgen Oncology Targeted Therapy Product and Solutions
    • 2.3.4 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zelgen Recent Developments and Future Plans
  • 2.4 Cipla
    • 2.4.1 Cipla Details
    • 2.4.2 Cipla Major Business
    • 2.4.3 Cipla Oncology Targeted Therapy Product and Solutions
    • 2.4.4 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Cipla Recent Developments and Future Plans
  • 2.5 Natco Pharma
    • 2.5.1 Natco Pharma Details
    • 2.5.2 Natco Pharma Major Business
    • 2.5.3 Natco Pharma Oncology Targeted Therapy Product and Solutions
    • 2.5.4 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Natco Pharma Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Oncology Targeted Therapy Product and Solutions
    • 2.6.4 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Novartis
    • 2.7.1 Novartis Details
    • 2.7.2 Novartis Major Business
    • 2.7.3 Novartis Oncology Targeted Therapy Product and Solutions
    • 2.7.4 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Novartis Recent Developments and Future Plans
  • 2.8 Roche
    • 2.8.1 Roche Details
    • 2.8.2 Roche Major Business
    • 2.8.3 Roche Oncology Targeted Therapy Product and Solutions
    • 2.8.4 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Roche Recent Developments and Future Plans
  • 2.9 Bristol-Myers Squibb
    • 2.9.1 Bristol-Myers Squibb Details
    • 2.9.2 Bristol-Myers Squibb Major Business
    • 2.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Product and Solutions
    • 2.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.10 Pfizer
    • 2.10.1 Pfizer Details
    • 2.10.2 Pfizer Major Business
    • 2.10.3 Pfizer Oncology Targeted Therapy Product and Solutions
    • 2.10.4 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Pfizer Recent Developments and Future Plans
  • 2.11 BEACON Pharma
    • 2.11.1 BEACON Pharma Details
    • 2.11.2 BEACON Pharma Major Business
    • 2.11.3 BEACON Pharma Oncology Targeted Therapy Product and Solutions
    • 2.11.4 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 BEACON Pharma Recent Developments and Future Plans
  • 2.12 Jiangxi Shanxiang
    • 2.12.1 Jiangxi Shanxiang Details
    • 2.12.2 Jiangxi Shanxiang Major Business
    • 2.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Product and Solutions
    • 2.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Jiangxi Shanxiang Recent Developments and Future Plans
  • 2.13 Yao Pharma
    • 2.13.1 Yao Pharma Details
    • 2.13.2 Yao Pharma Major Business
    • 2.13.3 Yao Pharma Oncology Targeted Therapy Product and Solutions
    • 2.13.4 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Yao Pharma Recent Developments and Future Plans
  • 2.14 CSPC
    • 2.14.1 CSPC Details
    • 2.14.2 CSPC Major Business
    • 2.14.3 CSPC Oncology Targeted Therapy Product and Solutions
    • 2.14.4 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 CSPC Recent Developments and Future Plans
  • 2.15 CHIATAI Tianqing
    • 2.15.1 CHIATAI Tianqing Details
    • 2.15.2 CHIATAI Tianqing Major Business
    • 2.15.3 CHIATAI Tianqing Oncology Targeted Therapy Product and Solutions
    • 2.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 CHIATAI Tianqing Recent Developments and Future Plans
  • 2.16 Simcere
    • 2.16.1 Simcere Details
    • 2.16.2 Simcere Major Business
    • 2.16.3 Simcere Oncology Targeted Therapy Product and Solutions
    • 2.16.4 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Simcere Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oncology Targeted Therapy Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Oncology Targeted Therapy by Company Revenue
    • 3.2.2 Top 3 Oncology Targeted Therapy Players Market Share in 2024
    • 3.2.3 Top 6 Oncology Targeted Therapy Players Market Share in 2024
  • 3.3 Oncology Targeted Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Oncology Targeted Therapy Market: Region Footprint
    • 3.3.2 Oncology Targeted Therapy Market: Company Product Type Footprint
    • 3.3.3 Oncology Targeted Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oncology Targeted Therapy Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Oncology Targeted Therapy Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Oncology Targeted Therapy Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Oncology Targeted Therapy Consumption Value by Type (2020-2031)
  • 6.2 North America Oncology Targeted Therapy Market Size by Application (2020-2031)
  • 6.3 North America Oncology Targeted Therapy Market Size by Country
    • 6.3.1 North America Oncology Targeted Therapy Consumption Value by Country (2020-2031)
    • 6.3.2 United States Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Oncology Targeted Therapy Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Oncology Targeted Therapy Consumption Value by Type (2020-2031)
  • 7.2 Europe Oncology Targeted Therapy Consumption Value by Application (2020-2031)
  • 7.3 Europe Oncology Targeted Therapy Market Size by Country
    • 7.3.1 Europe Oncology Targeted Therapy Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 7.3.3 France Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Oncology Targeted Therapy Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Oncology Targeted Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2020-2031)
    • 8.3.2 China Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 8.3.5 India Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Oncology Targeted Therapy Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Oncology Targeted Therapy Consumption Value by Type (2020-2031)
  • 9.2 South America Oncology Targeted Therapy Consumption Value by Application (2020-2031)
  • 9.3 South America Oncology Targeted Therapy Market Size by Country
    • 9.3.1 South America Oncology Targeted Therapy Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Oncology Targeted Therapy Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Oncology Targeted Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Oncology Targeted Therapy Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Oncology Targeted Therapy Market Drivers
  • 11.2 Oncology Targeted Therapy Market Restraints
  • 11.3 Oncology Targeted Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oncology Targeted Therapy Industry Chain
  • 12.2 Oncology Targeted Therapy Upstream Analysis
  • 12.3 Oncology Targeted Therapy Midstream Analysis
  • 12.4 Oncology Targeted Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oncology Targeted Therapy. Industry analysis & Market Report on Oncology Targeted Therapy is a syndicated market report, published as Global Oncology Targeted Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Oncology Targeted Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo